S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
NASDAQ:ACRX

AcelRx Pharmaceuticals News Headlines

$2.08
+0.22 (+11.83 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.91
Now: $2.08
$2.29
50-Day Range
$1.18
MA: $1.39
$2.18
52-Week Range
$0.70
Now: $2.08
$2.30
Volume15.44 million shs
Average Volume8.71 million shs
Market Capitalization$188.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.16

Headlines

AcelRx Pharmaceuticals (NASDAQ ACRX) News Headlines Today

Source:
SourceHeadline
AcelRx Pharmaceuticals (NASDAQ:ACRX) Trading Down 8.7%AcelRx Pharmaceuticals (NASDAQ:ACRX) Trading Down 8.7%
americanbankingnews.com - January 13 at 10:44 PM
ROCE Insights For AcelRx PharmaceuticalsROCE Insights For AcelRx Pharmaceuticals
benzinga.com - January 13 at 12:47 PM
Do Options Traders Know Something About AcelRx (ACRX) Stock We Dont?Do Options Traders Know Something About AcelRx (ACRX) Stock We Don't?
finance.yahoo.com - January 13 at 12:47 PM
AcelRx Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:ACRX)AcelRx Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:ACRX)
americanbankingnews.com - January 12 at 11:18 PM
AcelRx Pharmaceuticals (NASDAQ:ACRX) Trading 60.3% Higher AcelRx Pharmaceuticals (NASDAQ:ACRX) Trading 60.3% Higher
americanbankingnews.com - January 12 at 6:44 PM
These 2 Penny Stocks Could Surge Over 300%, Say AnalystsThese 2 Penny Stocks Could Surge Over 300%, Say Analysts
finance.yahoo.com - January 12 at 12:12 PM
AcelRx Pharmaceuticals (NASDAQ:ACRX) Trading Up 9.6%AcelRx Pharmaceuticals (NASDAQ:ACRX) Trading Up 9.6%
americanbankingnews.com - January 5 at 7:54 PM
AcelRx Pharmaceuticals (NASDAQ:ACRX) Shares Up 5.9%AcelRx Pharmaceuticals (NASDAQ:ACRX) Shares Up 5.9%
americanbankingnews.com - December 30 at 8:04 PM
AcelRx Announces $10 Million Registered Direct Common Stock OfferingAcelRx Announces $10 Million Registered Direct Common Stock Offering
finance.yahoo.com - December 10 at 9:14 AM
AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®
finance.yahoo.com - December 10 at 9:14 AM
AcelRx Pharmaceuticals to Present at LD Micro Main EventAcelRx Pharmaceuticals to Present at LD Micro Main Event
finance.yahoo.com - December 9 at 6:13 PM
AcelRx Pharmaceuticals Announces Partnership with the National Rural Health AssociationAcelRx Pharmaceuticals Announces Partnership with the National Rural Health Association
finance.yahoo.com - December 4 at 5:03 PM
Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?
finance.yahoo.com - December 2 at 6:18 PM
AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®
finance.yahoo.com - November 18 at 9:18 AM
AcelRx Pharmaceuticals: The $1 Million QuestionsAcelRx Pharmaceuticals: The $1 Million Questions
seekingalpha.com - November 11 at 2:38 PM
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their EstimatesAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
nasdaq.com - November 7 at 8:41 AM
Analysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest ResultsAnalysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest Results
finance.yahoo.com - November 7 at 8:41 AM
AcelRx Pharmaceuticals to Present at Credit Suisse 29th Annual Virtual Healthcare ConferenceAcelRx Pharmaceuticals to Present at Credit Suisse 29th Annual Virtual Healthcare Conference
finance.yahoo.com - November 6 at 1:58 PM
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q3 2020 Results - Earnings Call TranscriptAcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 10:52 PM
AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue EstimatesAcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 5 at 10:52 PM
AcelRx Pharmaceuticals EPS misses by $0.02, misses on revenueAcelRx Pharmaceuticals EPS misses by $0.02, misses on revenue
seekingalpha.com - November 5 at 5:52 PM
AcelRx Pharmaceuticals, Inc. to Host Earnings CallAcelRx Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 5:52 PM
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial ResultsAcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 5:52 PM
ACRX Jun 2021 2.500 callACRX Jun 2021 2.500 call
uk.finance.yahoo.com - October 30 at 6:46 PM
AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020
finance.yahoo.com - October 29 at 7:05 PM
AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseAcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 28 at 5:20 PM
Aclaris (ACRS) Begins Phase II Study on Eczema CandidateAclaris (ACRS) Begins Phase II Study on Eczema Candidate
finance.yahoo.com - October 21 at 1:28 PM
Is the Options Market Predicting a Spike in AcelRx (ACRX) Stock?Is the Options Market Predicting a Spike in AcelRx (ACRX) Stock?
nasdaq.com - October 12 at 5:23 PM
Thinking about buying stock in Tenax Therapeutics, Boxlight Corp, Blink Charging, Pacific Ethanol, or AcelRx Pharmaceuticals?Thinking about buying stock in Tenax Therapeutics, Boxlight Corp, Blink Charging, Pacific Ethanol, or AcelRx Pharmaceuticals?
marketwatch.com - September 23 at 1:51 PM
Reflecting on AcelRx Pharmaceuticals' (NASDAQ:ACRX) Share Price Returns Over The Last Three YearsReflecting on AcelRx Pharmaceuticals' (NASDAQ:ACRX) Share Price Returns Over The Last Three Years
finance.yahoo.com - September 23 at 8:50 AM
AcelRx Awarded U.S. Army Contract for DSUVIA®AcelRx Awarded U.S. Army Contract for DSUVIA®
prnewswire.com - September 22 at 12:46 PM
AcelRx awarded ~$3.6M contract for DSUVIA by U.S. ArmyAcelRx awarded ~$3.6M contract for DSUVIA by U.S. Army
seekingalpha.com - September 22 at 12:46 PM
AcelRx Announces DSUVIA® Added to the U.S. Department of Defenses Joint Deployment FormularyAcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary
prnewswire.com - September 14 at 12:28 PM
AcelRx announces DSUVIAs expanded accessAcelRx announces DSUVIA's expanded access
seekingalpha.com - September 14 at 12:28 PM
AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment FormularyAcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary
finance.yahoo.com - September 14 at 12:28 PM
AcelRx Pharmaceuticals to Present at Two Upcoming ConferencesAcelRx Pharmaceuticals to Present at Two Upcoming Conferences
finance.yahoo.com - September 10 at 7:32 PM
AcelRx initiates study of DSUVI in the perioperative setting on orthopedic patientsAcelRx initiates study of DSUVI in the perioperative setting on orthopedic patients
seekingalpha.com - August 24 at 3:07 PM
AcelRx initiates study of DSUVIA in the perioperative setting in orthopedic surgeryAcelRx initiates study of DSUVIA in the perioperative setting in orthopedic surgery
seekingalpha.com - August 24 at 3:07 PM
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative SettingAcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting
finance.yahoo.com - August 24 at 10:06 AM
AcelRx Pharma up 6% on data supporting preop use of pain med DsuviaAcelRx Pharma up 6% on data supporting preop use of pain med Dsuvia
seekingalpha.com - August 19 at 1:43 PM
AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®
finance.yahoo.com - August 19 at 8:42 AM
AcelRx Pharmaceuticals, Inc. (ACRX)AcelRx Pharmaceuticals, Inc. (ACRX)
uk.finance.yahoo.com - August 11 at 9:52 PM
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2020 Results - Earnings Call TranscriptAcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 12:35 AM
AcelRx Pharmaceuticals EPS beats by $0.06, beats on revenueAcelRx Pharmaceuticals EPS beats by $0.06, beats on revenue
seekingalpha.com - August 10 at 7:34 PM
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial ResultsAcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 10 at 7:34 PM
AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Lags Revenue EstimatesAcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 7:34 PM
AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020
finance.yahoo.com - August 3 at 7:38 PM
Earnings Preview: AcelRx Pharmaceuticals (ACRX) Q2 Earnings Expected to DeclineEarnings Preview: AcelRx Pharmaceuticals (ACRX) Q2 Earnings Expected to Decline
finance.yahoo.com - July 27 at 5:34 PM
New Forecasts: Heres What Analysts Think The Future Holds For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)New Forecasts: Here's What Analysts Think The Future Holds For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
finance.yahoo.com - July 25 at 1:08 PM
New Forecasts: Here's What Analysts Think The Future Holds For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)New Forecasts: Here's What Analysts Think The Future Holds For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
finance.yahoo.com - July 25 at 1:08 PM
This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.